| 1. |
Soodejani MT. Non-communicable diseases in the world over the past century: a secondary data analysis[J/OL]. Front Public Health, 2024, 12: 1436236. DOI: 10.3389/fpubh.2024.1436236.
|
| 2. |
Peng W, Zhang L, Wen F, et al. Trends and disparities in non-communicable diseases in the Western Pacific region[J/OL]. Lancet Reg Health West Pac, 2023, 43: 100938. DOI: 10.1016/j.lanwpc.2023.100938.
|
| 3. |
Li J, Pandian V, Davidson PM, et al. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Int J Surg, 2025, 111(3): 2385-2397.
|
| 4. |
Freihat O, Sipos D, Aamir M, et al. Global burden and future projections of non-communicable diseases (2000-2050): progress toward SDG 3.4 and disparities across regions and risk factors[J/OL]. PLoS One, 2025, 20(12): e0336036. DOI: 10.1371/journal.pone.0336036.
|
| 5. |
Murray CJL. Findings from the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2259-2262.
|
| 6. |
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2162-2203.
|
| 7. |
GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023[J]. Lancet, 2025, 406(10513): 1811-1872.
|
| 8. |
GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023[J]. Lancet, 2025, 406(10513): 1873-1922.
|
| 9. |
Chowdhury SR, Das DC, Sunna TC, et al. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis[J/OL]. EClinicalMedicine, 2023, 57: 101860. DOI: 10.1016/j.eclinm.2023.101860.
|
| 10. |
Murray CJL. The Global Burden of Disease Study at 30 years[J]. Nat Med, 2022, 28(10): 2019-2026.
|
| 11. |
GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 1989-2056.
|
| 12. |
Liang X, Lyu Y, Li J, et al. Global, regional, and national burden of preterm birth, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021[J/OL]. EClinicalMedicine, 2024, 76: 102840. DOI: 10.1016/j.eclinm.2024.102840.
|
| 13. |
Tan W, Chen L, Zhang Y, et al. Regional years of life lost, years lived with disability, and disability-adjusted life-years for severe mental disorder[J/OL]. Glob Health Res Policy, 2022, 7(1): 17. DOI: 10.1186/s41256-022-00253-3.
|
| 14. |
Thurber KA, Thandrayen J, Maddox R, et al. Reflection on modern methods: statistical, policy and ethical implications of using age-standardized health indicators to quantify inequities[J]. Int J Epidemiol, 2022, 51(1): 324-333.
|
| 15. |
Stang A, Gianicolo E. Age standardization of epidemiological frequency measures: part 37 of a series on the evaluation of scientific publications[J]. Dtsch Arztebl Int, 2025, 122(14): 387-392.
|
| 16. |
Tai SY, Liang FW, Hng YY, et al. Impacts of using different standard populations in calculating age-standardised death rates when age-specific death rates in the populations being compared do not have a consistent relationship: a cross-sectional population-based observational study on US state HIV death rates[J/OL]. BMJ Open, 2022, 12(4): e056441. DOI: 10.1136/bmjopen-2021-056441.
|
| 17. |
Khan HTA, Addo KM, Findlay H. Public health challenges and responses to the growing ageing populations: a review of literature[J/OL]. Public Health Chall, 2024, 3(3): e213. DOI: 10.1002/puh2.213.
|
| 18. |
Xi JY, Liang BH, Zhang WJ, et al. Effects of population aging on quality of life and disease burden: a population-based study[J/OL]. Glob Health Res Policy, 2025, 10(1): 2. DOI: 10.1186/s41256-024-00393-8.
|
| 19. |
Chen QF, van der Werf CS, Zhang ZY, et al. Global burden of disease and its risk factors for adults aged 70 and older across 204 countries and territories: a comprehensive analysis of the Global Burden of Disease Study 2021[J/OL]. BMC Geriatr, 2025, 25(1): 462. DOI: 10.1186/s12877-025-06095-1.
|
| 20. |
Hu X, Yu SJ, Gao YC, et al. Health inequality in the disease burden of non-communicable diseases among the elderly from 1990 to 2021, and projections to 2050: a systematic analysis of Global Burden of Disease Study[J/OL]. BMC Geriatr, 2025, 25(1): 693. DOI: 10.1186/s12877-025-06344-3.
|
| 21. |
Guirguis-Blake JM, Perdue LA, Coppola EL, et al. Interventions to prevent falls in older adults: updated evidence report and systematic review for the US Preventive Services Task Force[J]. JAMA, 2024, 332(1): 58-69.
|
| 22. |
Zhang H, Zhou XD, Shapiro MD, et al. Global burden of metabolic diseases, 1990-2021[J/OL]. Metabolism, 2024, 160: 155999. DOI: 10.1016/j.metabol.2024.155999.
|
| 23. |
Chen J, Li C, Bu CLN, et al. Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040[J]. Chin Med J (Engl), 2025, 138(11): 1334-1344.
|
| 24. |
Force LM, Kocarnik JM, May ML, et al. The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023[J]. Lancet, 2025, 406(10512): 1565-1586.
|
| 25. |
Mokdad AH, Ballestros K, Echko M, et al. The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 404(10469): 2314-2340.
|